Cargando…
Mybl2 rejuvenates heart explant‐derived cells from aged donors after myocardial infarction
While cell therapy is emerging as a promising option for patients with ischemic cardiomyopathy (ICM), the influence of advanced donor age and a history of ischemic injury on the reparative performance of these cells are not well defined. As such, intrinsic changes that result from advanced donor age...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433005/ https://www.ncbi.nlm.nih.gov/pubmed/32558221 http://dx.doi.org/10.1111/acel.13174 |